New York J 2306: Memorializing Governor Kathy Hochul to proclaim November 2026, as Alpha-1 Awareness Month in the State of New York

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
J02306 Summary:

BILL NOJ02306 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORTEDISCO

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

&nbsp

Go to top J02306 Actions:

BILL NOJ02306 

&nbsp

05/29/2026REFERRED TO FINANCE

06/02/2026REPORTED TO CALENDAR FOR CONSIDERATION

06/02/2026ADOPTED

06/04/2026REPORTED TO CALENDAR FOR CONSIDERATION

06/04/2026ADOPTED

Go to topJ02306 Committee&nbspVotes:

Go to topJ02306 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topJ02306 Text:

Senate Resolution No. 2306

BY: Senator TEDISCO

 MEMORIALIZING Governor Kathy Hochul to proclaim
 November 2026, as Alpha-1 Awareness Month in the
 State of New York

 WHEREAS, It is the custom of this Legislative Body to recognize
official months that are set aside to increase awareness of serious
diseases that affect the lives of citizens of New York State; and

 WHEREAS, Attendant to such concern, and in full accord with its
long-standing traditions, this Legislative Body is justly proud to
memorialize Governor Kathy Hochul to proclaim November 2026, as Alpha-1
Awareness Month in the State of New York, in conjunction with the
observance of National Alpha-1 Awareness Month; and

 WHEREAS, Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic
condition that may result in serious lung disease or liver disease; it
occurs when there is a severe lack of a protein in the blood called
Alpha-1 Antitrypsin (AAT) which is mainly produced by the liver; and

 WHEREAS, The main function of AAT is to protect the lungs from
inflammation caused by infection and inhaled irritants such as tobacco
smoke; the low level of AAT in the blood occurs because the AAT is
abnormal and cannot be released from the liver at the normal rate
leading to a buildup of abnormal AAT in the liver which can cause liver
disease; and

 WHEREAS, People with Alpha-1 antitrypsin deficiency usually develop
the first signs and symptoms of lung disease between ages 20 and 50; the
earliest symptoms are shortness of breath following mild activity,
reduced ability to exercise, and wheezing; and

 WHEREAS, Other signs and symptoms can include unintentional weight
loss, recurring respiratory infections, fatigue, and rapid heartbeat
upon standing; affected individuals often develop emphysema; and

 WHEREAS, About 10 percent of infants with Alpha-1 develop liver
disease and approximately 15 percent of adults will develop liver damage
due to the formation of scar tissue in the liver; and

 WHEREAS, In rare cases, people with Alpha-1 develop a skin condition
called panniculitis, which is characterized by hardened skin with
painful lumps or patches; and

 WHEREAS, There are treatments and preventative measures that may
slow the progression of lung disease and help one take control of their
health; the specific therapy for the treatment of Alpha-1 related lung
disease is augmentation therapy, the use of alpha-1 antitrypsin protein;
and

 WHEREAS, The Alpha-1 Foundation Support Group Network is a
collective of more than 80 affiliated support groups dedicated to
providing support, education and information to people affected by
Alpha-1 while extending the mission of the Alpha-1 Foundation; and

 WHEREAS, Under the luminous leadership of Richard Lovrich, the
Capital Region of New York Alpha-1 Support Group helps people develop an
enhanced, healthier sense of personal identity and a connection with the
greater Alpha-1 community; and

 WHEREAS, It is imperative that there be greater awareness of this
serious health condition, and more must be done to increase activity at
the local, State and National levels; now, therefore, be it

 RESOLVED, That this Legislative Body pause in its deliberations to
memorialize Governor Kathy Hochul to proclaim November 2026, as Alpha-1
Awareness Month in the State of New York; and be it further

 RESOLVED, That copies of this Resolution, suitably engrossed, be
transmitted to The Honorable Kathy Hochul, Governor of the State of New
York and Richard Lovrich, Leader of New York Capital Region Alpha-1
Support Group.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps